Patisiran
ATC N07XX12 · 7 markets · 8 records
Patisiran
Forms
AU 2 records · 2 strengths
- 10.5 mginjectionONPATTRO patisiran 10 mg/5 mL concentrated injection for infusion vial
Records without a stated strength · 1 Onpattro
US 1 records · 1 strengths
- 2 mginjectionOnpattro
GB 1 records · 1 strengths
- 10 mg/5 mLinjectionOnpattro 10mg/5ml concentrate for solution for infusion vials
CA 1 records · 1 strengths
- 2 mgliquidOnpattro
ES 1 records · 1 strengths
- 2 mg/1 mLinjectionOnpattro
TW 1 records · 1 strengths
- 2 mginjectionOnpattro 2mg/mL concentrate for solution for infusion詠葆玖靜脈輸注濃縮液 2毫克/毫升
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Onpattro
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.